565 related articles for article (PubMed ID: 20403936)
1. Tolerance and withdrawal from prolonged opioid use in critically ill children.
Anand KJ; Willson DF; Berger J; Harrison R; Meert KL; Zimmerman J; Carcillo J; Newth CJ; Prodhan P; Dean JM; Nicholson C;
Pediatrics; 2010 May; 125(5):e1208-25. PubMed ID: 20403936
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dexmedetomidine for prevention of withdrawal syndrome in the pediatric intensive care unit: protocol for an adaptive, multicenter, randomized, double-blind, placebo-controlled, non-profit clinical trial.
Mondardini MC; Sperotto F; Daverio M; Caramelli F; Gregori D; Caligiuri MF; Vitale F; Cecini MT; Piastra M; Mancino A; Pettenazzo A; Conti G; Amigoni A
Trials; 2019 Dec; 20(1):710. PubMed ID: 31829274
[TBL] [Abstract][Full Text] [Related]
3. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit.
Tobias JD
Crit Care Med; 2000 Jun; 28(6):2122-32. PubMed ID: 10890677
[TBL] [Abstract][Full Text] [Related]
4. Remifentanil-induced tolerance, withdrawal or hyperalgesia in infants: a randomized controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of paediatric intensive care patients.
Welzing L; Link F; Junghaenel S; Oberthuer A; Harnischmacher U; Stuetzer H; Roth B
Neonatology; 2013; 104(1):34-41. PubMed ID: 23635551
[TBL] [Abstract][Full Text] [Related]
5. [Do opioids induce hyperalgesia?].
Zöllner C
Anaesthesist; 2010 Nov; 59(11):983-6, 988-93. PubMed ID: 20967403
[TBL] [Abstract][Full Text] [Related]
6. Frequency, risk factors and symptomatology of iatrogenic withdrawal from opioids and benzodiazepines in critically Ill neonates, children and adults: A systematic review of clinical studies.
Duceppe MA; Perreault MM; Frenette AJ; Burry LD; Rico P; Lavoie A; Gélinas C; Mehta S; Dagenais M; Williamson DR
J Clin Pharm Ther; 2019 Apr; 44(2):148-156. PubMed ID: 30569508
[TBL] [Abstract][Full Text] [Related]
7. Iatrogenic Opioid Withdrawal in Critically Ill Patients: A Review of Assessment Tools and Management.
Chiu AW; Contreras S; Mehta S; Korman J; Perreault MM; Williamson DR; Burry LD
Ann Pharmacother; 2017 Dec; 51(12):1099-1111. PubMed ID: 28793780
[TBL] [Abstract][Full Text] [Related]
8. Patient, Process, and System Predictors of Iatrogenic Withdrawal Syndrome in Critically Ill Children.
Best KM; Wypij D; Asaro LA; Curley MA;
Crit Care Med; 2017 Jan; 45(1):e7-e15. PubMed ID: 27513532
[TBL] [Abstract][Full Text] [Related]
9. Utility of transdermal fentanyl for prevention of iatrogenic opioid abstinence syndrome in children.
Johnson PN; Harrison D; Allen C
J Opioid Manag; 2010; 6(2):117-24. PubMed ID: 20481176
[TBL] [Abstract][Full Text] [Related]
10. Patterns of Sedation Weaning in Critically Ill Children Recovering From Acute Respiratory Failure.
Best KM; Asaro LA; Franck LS; Wypij D; Curley MA;
Pediatr Crit Care Med; 2016 Jan; 17(1):19-29. PubMed ID: 26509816
[TBL] [Abstract][Full Text] [Related]
11. Opioid withdrawal signs and symptoms in children: frequency and determinants.
Fisher D; Grap MJ; Younger JB; Ameringer S; Elswick RK
Heart Lung; 2013; 42(6):407-13. PubMed ID: 24008186
[TBL] [Abstract][Full Text] [Related]
12. Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patients.
Franck LS; Scoppettuolo LA; Wypij D; Curley MAQ
Pain; 2012 Jan; 153(1):142-148. PubMed ID: 22093817
[TBL] [Abstract][Full Text] [Related]
13. Perioperative opiate requirements in children with previous opiate infusion.
Fanning JJ; Stucke AG; Christensen MA; Cassidy LD; Berens RJ
Paediatr Anaesth; 2012 Mar; 22(3):203-8. PubMed ID: 22070472
[TBL] [Abstract][Full Text] [Related]
14. Nurse-driven pediatric analgesia and sedation protocol reduces withdrawal symptoms in critically ill medical pediatric patients.
Neunhoeffer F; Kumpf M; Renk H; Hanelt M; Berneck N; Bosk A; Gerbig I; Heimberg E; Hofbeck M
Paediatr Anaesth; 2015 Aug; 25(8):786-794. PubMed ID: 25810086
[TBL] [Abstract][Full Text] [Related]
15. Methadone analgesia in the critically ill.
Elefritz JL; Murphy CV; Papadimos TJ; Lyaker MR
J Crit Care; 2016 Aug; 34():84-8. PubMed ID: 27288616
[TBL] [Abstract][Full Text] [Related]
16. Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients.
Franck LS; Naughton I; Winter I
Intensive Crit Care Nurs; 2004 Dec; 20(6):344-51. PubMed ID: 15567675
[TBL] [Abstract][Full Text] [Related]
17. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Candiotti KA; Gitlin MC
Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of adverse reactions to the weaning of opioids and benzodiazepines among critically ill children.
Ducharme C; Carnevale FA; Clermont MS; Shea S
Intensive Crit Care Nurs; 2005 Jun; 21(3):179-86. PubMed ID: 15907670
[TBL] [Abstract][Full Text] [Related]
19. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
Pergolizzi JV; Raffa RB; Rosenblatt MH
J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with iatrogenic opioid and benzodiazepine withdrawal in critically ill pediatric patients: a systematic review and conceptual model.
Best KM; Boullata JI; Curley MA
Pediatr Crit Care Med; 2015 Feb; 16(2):175-83. PubMed ID: 25560429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
